Lenalidomide Capsule
FDA Label NDC 70771-1676

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Lenalidomide (NDC 70771-1676). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1677-7

Lenalidomide Capsules, 5 mg

28 Capsules

Rx only

5 mg Label (E67d1c36 75f9 4c68 B728 4f4995ae0d77 01)

NDC 70771-1678-7

Lenalidomide Capsules, 10 mg

28 Capsules

Rx only

10 mg Label (E67d1c36 75f9 4c68 B728 4f4995ae0d77 02)

NDC 70771-1679-8

Lenalidomide Capsules, 15 mg

21 Capsules

Rx only

15 mg Label (E67d1c36 75f9 4c68 B728 4f4995ae0d77 03)

NDC 70771-1681-8

Lenalidomide Capsules, 25 mg

21 Capsules

Rx only

25 mg Label (E67d1c36 75f9 4c68 B728 4f4995ae0d77 04)

* Please review the disclaimer below.